Although both Novera Retatrutide and Hyalgan Durolane target joint pain , their methods of function are distinctly contrasting. the new Retatrutide is a double receptor influencing GLP-1 and glucose-dependent insulinotropic , primarily used for body management , which potentially secondarily all